Alan Mendelsohn, MD, Shares Insights Into Congenital Ichthyosis Patient Care and the Development of TMB-001
The congenital ichthyosis session the 2024 AAD Annual Meeting covered real-world patient cases and treatments on the horizon.
Trial Shows Positive Results With Isotretinoin Treatment in Congenital Ichthyosis
Alan Mendelsohn, MD, presented captivating Phase 3 TMB-001 PK Data in a poster session.
Alan Mendelsohn, MD, Reviews Phase 3 TMB-001 PK Data for Congenital Ichthyosis
New pharmacokinetic phase 3 data will be presented at the 2023 Society for Pediatric Dermatology meeting next week.